Pain ‐ absence of pain at 12 months · septic arthritis in children taking antibiotics
Corticosteroids (dexamethasone) may leads to higher pain ‐ absence of pain at 12 months compared with placebo (low certainty).
1 finding from 1 review
Activities of daily living · septic arthritis in children taking antibiotics
1 finding from 1 review
Number of participants with normal physical joint function ‐ normal function at 12 months of · septic arthritis in children taking antibiotics
Corticosteroids (dexamethasone) may leads to higher number of participants with normal physical joint function ‐ normal… compared with placebo (low certainty).
1 finding from 1 review
Number of days of antibiotic treatment ‐ number of days of intravenous antibiotic treatment · septic arthritis in children taking antibiotics
Corticosteroids (dexamethasone) showed no clear difference in number of days of antibiotic treatment ‐ number of days of… compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · septic arthritis in children taking antibiotics
1 finding from 1 review
Total adverse events at 12 months · septic arthritis in children taking antibiotics
1 finding from 1 review
Serious adverse events at 12 months · septic arthritis in children taking antibiotics
1 finding from 1 review
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with hip osteoarthritis
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · patients with hip osteoarthritis
1 finding from 1 review
Quality of life (mental component) (short‐term) SF‐36 physical component scale from 0 to 100 (higher is better quality of life). · patients with hip osteoarthritis
1 finding from 1 review
Number of participants reporting an adverse event · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Outcomesa · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Pain (short‐term) · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Function (short‐term) · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Symptom severity (modified WOMAC total) (range 0‐1,600, with lower scores indicating decrease in symptom severity) · patients with hip osteoarthritis
1 finding from 1 review
Number of participants reporting an adverse event · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis
1 finding from 1 review
Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review